About lino Biotech
lino Biotech is a company based in Zurich (Switzerland) founded in 2020 by Andreas Frutiger and Tilman Hoss was acquired by Miltenyi Biotec in February 2023. lino Biotech offers products and services including MACS® Matchmaker, Sensor Chips, DNA Adaptors, and Kits.
- Headquarter Zurich, Switzerland
- Founders Andreas Frutiger, Tilman Hoss
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lino Biotech Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Roche
& 2 more
-
Employee Count
Not available
-
Acquired by
Miltenyi Biotec
(Feb 22, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of lino Biotech
lino Biotech offers a comprehensive portfolio of products and services, including MACS® Matchmaker, Sensor Chips, DNA Adaptors, and Kits.
Platform for quantitative analysis of biomolecular interactions.
Components for measuring interactions in biological matrices.
Tools for DNA-based binder development in research.
Packages for automated biological interaction assays.
People of lino Biotech
Unlock access to complete
Unlock access to complete
Funding Insights of lino Biotech
Investors in lino Biotech
lino Biotech has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche, Miltenyi Biotec and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
Locked | Locked | Locked | |
|
Develops tools and products for research and clinical application
|
Locked | Locked | Locked |
Investor details for lino Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by lino Biotech
Investment portfolio details for lino Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - lino Biotech
Detailed financials for lino Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lino Biotech Comparisons
Peer comparison for lino Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of lino Biotech
Detailed competitors of lino Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lino Biotech
Complete news archive for lino Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about lino Biotech
lino Biotech was founded in 2020.
lino Biotech is headquartered in Zurich, Switzerland.
Focal molography technology was established in 2020 in Zurich, Switzerland, within the biotechnology sector. Photolithography, molecular self-assembly, and optical systems are integrated into a device for label-free assays. Molecular interactions are detected in living cells or unprocessed biological samples. Operations focus on advancing detection methods for research applications.
lino Biotech offers MACS® Matchmaker, Sensor Chips, DNA Adaptors, and Kits.
lino Biotech has 3 investors. Key investors include Roche, Miltenyi Biotec, and High-Tech Gründerfonds.